CytomX Therapeutics (CTMX)
3.43
-0.01 (0.29%)
Upcoming Events
Latest Headlines
CytomX Therapeutics (CTMX) PT Lowered to $14 at Guggenheim
August 10, 2026 7:28 AM - StreetInsider
Form SCHEDULE 13G CytomX Therapeutics, Filed by: STATE STREET CORP
August 7, 2026 9:23 AM - SEC Filing
Form S-8 CytomX Therapeutics,
August 6, 2026 4:32 PM - SEC Filing
CytomX Therapeutics (CTMX) Misses Q2 EPS by 1c
August 6, 2026 4:18 PM - StreetInsider
Form 8-K CytomX Therapeutics, For: Aug 06
August 6, 2026 4:16 PM - SEC Filing
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
August 6, 2026 4:15 PM - Globe NewsWire
Form 10-Q CytomX Therapeutics, For: Jun 30
August 6, 2026 4:08 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Aug 03 Filed by: Carvajal Alejandra
August 5, 2026 7:33 PM - SEC Filing
Form 3 CytomX Therapeutics, For: Aug 03 Filed by: Carvajal Alejandra
August 5, 2026 7:32 PM - SEC Filing
Form SCHEDULE 13G CytomX Therapeutics, Filed by: BANK OF AMERICA CORP /DE/
August 3, 2026 12:05 PM - SEC Filing
CytomX Therapeutics names Alejandra Carvajal as chief legal officer
August 3, 2026 8:00 AM - StreetInsider
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
August 3, 2026 8:00 AM - Globe NewsWire
Form 4 CytomX Therapeutics, For: Jul 24 Filed by: Fuchs Charles S.
July 30, 2026 5:07 PM - SEC Filing
Form 3 CytomX Therapeutics, For: Jul 24 Filed by: Fuchs Charles S.
July 30, 2026 5:06 PM - SEC Filing
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G CytomX Therapeutics, Filed by: BlackRock, Inc.
July 27, 2026 4:26 PM - SEC Filing
Form 8-K CytomX Therapeutics, For: Jul 24
July 27, 2026 8:05 AM - SEC Filing
CytomX Therapeutics adds oncologist Charles Fuchs to its board
July 27, 2026 8:00 AM - StreetInsider
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
July 27, 2026 8:00 AM - Globe NewsWire
Form 4 CytomX Therapeutics, For: Jun 17 Filed by: Su Zhen
June 22, 2026 4:53 PM - SEC Filing
Form 8-K CytomX Therapeutics, For: Jun 17
June 22, 2026 4:52 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Jun 17 Filed by: Young Matthew P.
June 22, 2026 4:52 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Jun 17 Filed by: Mohindru Mani
June 22, 2026 4:50 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Jun 17 Filed by: Meyers James R
June 22, 2026 4:50 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Jun 17 Filed by: Gilbert Halley E
June 22, 2026 4:49 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Jun 17 Filed by: Ashworth Alan
June 22, 2026 4:48 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Jun 17 Filed by: Jones Elaine V
June 22, 2026 4:46 PM - SEC Filing
Form 4 CytomX Therapeutics, For: Jun 15 Filed by: Ogden Christopher
June 17, 2026 6:39 PM - SEC Filing
Form 8-K CytomX Therapeutics, For: May 29
June 3, 2026 4:15 PM - SEC Filing
CytomX expands Regeneron collaboration, receives $37 million payment
June 3, 2026 8:03 AM - StreetInsider
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
June 3, 2026 8:00 AM - Globe NewsWire
CytomX Therapeutics to Present at Upcoming June Investor Conferences
May 21, 2026 8:00 AM - Globe NewsWire
Wolfe Research Starts CytomX Therapeutics (CTMX) at Outperform
May 19, 2026 5:32 AM - StreetInsider
CytomX hires Mamata Gokhale as regulatory affairs head
May 18, 2026 8:01 AM - StreetInsider
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs
May 18, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Seven Fleet Capital Management LP
May 15, 2026 5:12 PM - SEC Filing
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Longitude Capital Partners V, LLC
May 15, 2026 4:50 PM - SEC Filing
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
May 15, 2026 4:43 PM - SEC Filing
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Kynam Capital Management, LP
May 15, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 4:00 PM - SEC Filing
Full Article List
